
After successfully using zzso (30 zzso and zzso zzso zzso in ten three-day courses for progressive zzso zzso a subsequent protocol reduced the daily doses of zzso (to 25 zzso and zzso (to 100 zzso with the objective of achieving the same response and three-year zzso rates with lower zzso and zzso We treated 37 patients zzso age 6 zzso 23 had zzso zzso and nine were zzso zzso zzso were clinical in 13 cases and zzso in 24, and zzso zzso zzso zzso zzso zzso zzso zzso zzso and zzso zzso zzso Treatment was prompted by zzso evidence of progression and/or clinical deterioration a median 18 months after the first zzso After initial zzso staging, neurological and clinical examinations were performed before each chemotherapy cycle, with zzso after the first three courses and every three months zzso After a median 48 months, a volume reduction was appreciable in 24 cases zzso and response was maximum 12 months after starting zzso The three-year zzso and zzso rates were 65 and zzso zzso zzso zzso or functional improvements were seen in zzso zzso No children had a zzso zzso below zzso zzso toxicity caused damage in zzso zzso The previous protocol had achieved volume reductions in zzso of cases, causing zzso damage zzso zzso in zzso zzso zzso zzso with three-year zzso and zzso rates of 70 and zzso zzso Lower doses of zzso are still effective in progressive zzso zzso with less acute and persistent zzso 

